A former medical scientist says he is “not convinced” the only “solutions” to stopping the spread of the Ebola virus are using the same technology as the US and British governments to control the spread.
Key points:Dr Richard Lynam, who worked for Australia’s Medical Research Council, said the technology developed by the World Health Organization (WHO) would not work as well as he believed it wouldIn the meantime, Dr Lynam said he is working to develop an “aerosolized version” of the treatment he uses at the Royal Melbourne Hospital, a move he says will stop the spread in the event of a major outbreak.
The Royal Melbourne’s Dr Lula says he has been working with a team of Australian researchers to develop a “aerospoiling” treatment that would kill the virus and stop the virus from getting out of control.
Dr Lynam’s research on Ebola began in the early 1980s, when he was the director of the Queensland University of Technology’s Laboratory of Immunology and Immunobiology.
Dr Nilesh Kumar, who is now the chief executive of the Medical Research and Training Council of Australia (MTRCA), which oversees the work of the Royal Medical College of Australia, said he was not convinced by the WHO’s assertion that the use of aerosolized drugs and vaccines would not be effective.
“They are suggesting that these are the only solutions, they’re saying that aerosolised technology will work but it won’t,” he told ABC Radio Melbourne’s Breakfast program.
“I would think they’re wrong.”
Dr Lula said he had been working on the idea of using aerosolisation as a “first-line” treatment for Ebola for over a decade.
Dr Kumar, whose team was also involved in developing a treatment for the coronavirus, said aerosol therapy had been “fraught with problems” and had been developed in “an extremely limited fashion”.
“The only thing that I would say that has been proven is that it’s effective in preventing the spread,” he said.
“What we’re doing here is trying to improve the technology.
If we do it right, it should be effective.”
Dr Kumar said he understood why Dr Latic was sceptical of the technology’s effectiveness, given the challenges involved in making a treatment effective.”[There’s] a whole range of different things to worry about and a whole host of different tests that need to be done to prove that the treatment is effective and not going to cause problems, he said, adding that he was confident that the technology would work.”
We’re doing everything we can to get it right.
“The Royal Medical School in Victoria, which is the world’s largest medical school, said in a statement that it was “delighted to have Dr Llamys work in our partnership to develop this technology”.”
This is a very promising technology, and we are working with Dr Lautys team to develop our own version that we believe will be able to protect us against the Ebola pandemic and the related medical conditions associated with it,” the statement read.”
It is our hope that this technology can help reduce the spread and improve our overall health and wellbeing.
“Dr Nilsen said the Royal College of Surgeons of Australia’s Board of Directors welcomed Dr Louli’s research and welcomed the Royal Academy of Sciences’ support.”
Dr Loulic’s research has made the world a safer place and it is vital that we use this research to protect lives, improve health outcomes and ultimately improve our quality of life,” Dr Nilsens statement read, without mentioning Dr Lancas research.
The WHO’s statement said that the aerosolization technology developed to treat the Ebola outbreak was not suitable for use against the virus because it could not be used to kill the viral particle in the air.
However, Dr Niles said he did not think the aerosols were the only options.”
Dr Llamos work in the United States led to a vaccine being developed for the virus.”
The technology is the technology, but there are other ways that it could be used.”
Dr Llamos work in the United States led to a vaccine being developed for the virus.
The United States National Institutes of Health (NIH) and the Department of Health and Human Services announced in June that they were working together to develop the Ebola vaccines, with the U.S. government set to pay a total of $US1 billion ($1.6 billion) to develop, produce and deliver the vaccines.
Dr John Sarno, who was the chief scientific officer of the United Kingdom’s Royal College, said there was a need for a vaccine.
“The UK vaccine is going to be a big step forward in terms of protecting the public, but I do think that the Ebola vaccination is a major step forward,” he added. The first
